Adlai Nortye Group Ltd. (ANL)
15.52
+0.52
(+3.47%)
USD |
NASDAQ |
Sep 16, 16:00
15.48
-0.04
(-0.23%)
After-Hours: 20:00
Adlai Nortye Group Enterprise Value : 883.67M for Sept. 16, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 16, 2026 | 883.67M |
| September 15, 2026 | 853.12M |
| September 14, 2026 | 907.75M |
| September 11, 2026 | 865.46M |
| September 10, 2026 | 858.41M |
| September 09, 2026 | 835.21M |
| September 08, 2026 | 883.08M |
| September 04, 2026 | 853.71M |
| September 03, 2026 | 838.44M |
| September 02, 2026 | 785.87M |
| September 01, 2026 | 772.66M |
| August 31, 2026 | 805.55M |
| August 28, 2026 | 783.82M |
| August 27, 2026 | 813.19M |
| August 26, 2026 | 856.65M |
| August 25, 2026 | 779.12M |
| August 24, 2026 | 803.79M |
| August 21, 2026 | 776.77M |
| August 20, 2026 | 777.94M |
| August 19, 2026 | 813.77M |
| August 18, 2026 | 803.79M |
| August 17, 2026 | 755.63M |
| August 14, 2026 | 750.34M |
| August 13, 2026 | 727.43M |
| August 12, 2026 | 740.94M |
| Date | Value |
|---|---|
| August 11, 2026 | 740.35M |
| August 10, 2026 | 749.16M |
| August 07, 2026 | 752.10M |
| August 06, 2026 | 784.99M |
| August 05, 2026 | 739.77M |
| August 04, 2026 | 735.66M |
| August 03, 2026 | 735.07M |
| July 31, 2026 | 735.66M |
| July 30, 2026 | 735.66M |
| July 29, 2026 | 683.38M |
| July 28, 2026 | 717.45M |
| July 27, 2026 | 680.45M |
| July 24, 2026 | 706.29M |
| July 23, 2026 | 748.58M |
| July 22, 2026 | 750.93M |
| July 21, 2026 | 735.66M |
| July 20, 2026 | 675.75M |
| July 17, 2026 | 649.32M |
| July 16, 2026 | 638.74M |
| July 15, 2026 | 596.45M |
| July 14, 2026 | 512.46M |
| July 13, 2026 | 514.81M |
| July 10, 2026 | 551.82M |
| July 09, 2026 | 599.39M |
| July 08, 2026 | 570.02M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Zai Lab Ltd. | 2.306B |
| Kintor Pharmaceutical Ltd. | -- |
| Jacobio Pharmaceuticals Group Co., Ltd. | -- |
| Q32 Bio, Inc. | 159.65M |
| Prelude Therapeutics, Inc. | 222.41M |
Enterprise Value Related Metrics
| Earnings Yield | -3.50% |
| Normalized Earnings Yield | -3.499 |